182 related articles for article (PubMed ID: 35196205)
1. Circular RNA SET domain protein 3 promotes nasopharyngeal carcinoma proliferation, cisplatin resistance, and protein kinase B / mammalian target of rapamycin pathway activation by modulating microRNA-147a expression.
Deng G; Wang F; Song Y
Bioengineered; 2022 Mar; 13(3):5843-5854. PubMed ID: 35196205
[TBL] [Abstract][Full Text] [Related]
2. Long Noncoding RNA HOXA11-AS Modulates the Resistance of Nasopharyngeal Carcinoma Cells to Cisplatin via miR-454-3p/c-Met.
Lin FJ; Lin XD; Xu LY; Zhu SQ
Mol Cells; 2020 Oct; 43(10):856-869. PubMed ID: 33115978
[TBL] [Abstract][Full Text] [Related]
3. circSETD3 regulates MAPRE1 through miR-615-5p and miR-1538 sponges to promote migration and invasion in nasopharyngeal carcinoma.
Tang L; Xiong W; Zhang L; Wang D; Wang Y; Wu Y; Wei F; Mo Y; Hou X; Shi L; Xiong F; Zhang S; Gong Z; Liao Q; Xiang B; Zhang W; Zhou M; Li X; Li G; Guo C; Zeng Z
Oncogene; 2021 Jan; 40(2):307-321. PubMed ID: 33122825
[TBL] [Abstract][Full Text] [Related]
4. HOTAIR mediates cisplatin resistance in nasopharyngeal carcinoma by regulating miR-106a-5p/SOX4 axis.
Cao W; Sun Y; Liu L; Yu J; Ji J; Wang Y; Yang J
Bioengineered; 2022 Mar; 13(3):6567-6578. PubMed ID: 35227173
[TBL] [Abstract][Full Text] [Related]
5. miR-21 modulates cisplatin resistance of gastric cancer cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway.
Gu Y; Fei Z; Zhu R
Anticancer Drugs; 2020 Apr; 31(4):385-393. PubMed ID: 31913198
[TBL] [Abstract][Full Text] [Related]
6. Circular RNA UBAP2 facilitates the cisplatin resistance of triple-negative breast cancer via microRNA-300/anti-silencing function 1B histone chaperone/PI3K/AKT/mTOR axis.
Wang L; Yang X; Zhou F; Sun X; Li S
Bioengineered; 2022 Mar; 13(3):7197-7208. PubMed ID: 35263216
[TBL] [Abstract][Full Text] [Related]
7. Radiosensitizer EXO-miR-197-3p Inhibits Nasopharyngeal Carcinoma Progression and Radioresistance by Regulating the AKT/mTOR Axis and HSPA5-mediated Autophagy.
Jiang J; Tang Q; Gong J; Jiang W; Chen Y; Zhou Q; Aldeen A; Wang S; Li C; Lv W; Du T; Wang X; Long X; Feng X
Int J Biol Sci; 2022; 18(5):1878-1895. PubMed ID: 35342334
[TBL] [Abstract][Full Text] [Related]
8. miR-205-5p regulates epithelial-mesenchymal transition by targeting PTEN via PI3K/AKT signaling pathway in cisplatin-resistant nasopharyngeal carcinoma cells.
Zhang P; Lu X; Shi Z; Li X; Zhang Y; Zhao S; Liu H
Gene; 2019 Aug; 710():103-113. PubMed ID: 31158447
[TBL] [Abstract][Full Text] [Related]
9. Long non‑coding RNA KCNQ1OT1 promotes nasopharyngeal carcinoma cell cisplatin resistance via the miR‑454/USP47 axis.
Yuan F; Lou Z; Zhou Z; Yan X
Int J Mol Med; 2021 Apr; 47(4):. PubMed ID: 33576460
[TBL] [Abstract][Full Text] [Related]
10. CircLASP1 silence strengthens the therapeutic effects of MK-2206 on nasopharyngeal cancer through upregulating miR-625.
Xu LN; Liu SL; Yang Y; Shu L; Sun Y
Cancer Sci; 2023 May; 114(5):2123-2138. PubMed ID: 36644819
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-101-3p inhibits nasopharyngeal carcinoma cell proliferation and cisplatin resistance through ZIC5 down-regulation by targeting SOX2.
Li T; Zhang G; Li W; Xiao J; Zhou Z; Tan G; Ai J
Biol Chem; 2023 Sep; 404(10):961-975. PubMed ID: 36752150
[TBL] [Abstract][Full Text] [Related]
12. Cinobufotalin powerfully reversed EBV-miR-BART22-induced cisplatin resistance via stimulating MAP2K4 to antagonize non-muscle myosin heavy chain IIA/glycogen synthase 3β/β-catenin signaling pathway.
Liu Y; Jiang Q; Liu X; Lin X; Tang Z; Liu C; Zhou J; Zhao M; Li X; Cheng Z; Li L; Xie Y; Liu Z; Fang W
EBioMedicine; 2019 Oct; 48():386-404. PubMed ID: 31594754
[TBL] [Abstract][Full Text] [Related]
13. APLNR is involved in ATRA-induced growth inhibition of nasopharyngeal carcinoma and may suppress EMT through PI3K-Akt-mTOR signaling.
Liu Y; Liu Q; Chen S; Liu Y; Huang Y; Chen P; Li X; Gao G; Xu K; Fan S; Zeng Z; Xiong W; Tan M; Li G; Zhang W
FASEB J; 2019 Nov; 33(11):11959-11972. PubMed ID: 31408612
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of lncRNA HAGLROS enhances the development of nasopharyngeal carcinoma via modulating miR-100/ATG14 axis-mediated PI3K/AKT/mTOR signals.
Zhang W; Zhang Y; Xi S
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3043-3052. PubMed ID: 31334669
[TBL] [Abstract][Full Text] [Related]
15. microRNA-10b confers cisplatin resistance by activating AKT/mTOR/P70S6K signaling via targeting PPARγ in esophageal cancer.
Wu K; Hu Y; Yan K; Qi Y; Zhang C; Zhu D; Liu D; Zhao S
J Cell Physiol; 2020 Feb; 235(2):1247-1258. PubMed ID: 31267531
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-577/EIF5A2 axis suppressed the proliferation of DDP-resistant nasopharyngeal carcinoma cells by blocking TGF-β signaling pathway.
Wu R; Zhong Q; Liu H; Liu S
Chem Biol Drug Des; 2023 Oct; 102(4):815-827. PubMed ID: 37500510
[TBL] [Abstract][Full Text] [Related]
17. SATB1 Knockdown Inhibits Proliferation and Invasion and Decreases Chemoradiation Resistance in Nasopharyngeal Carcinoma Cells by Reversing EMT and Suppressing MMP-9.
Zhou D; Ye C; Pan Z; Deng Y
Int J Med Sci; 2021; 18(1):42-52. PubMed ID: 33390772
[No Abstract] [Full Text] [Related]
18. Inhibition of Autophagy Potentiated the Antitumor Effect of Nedaplatin in Cisplatin-Resistant Nasopharyngeal Carcinoma Cells.
Liu Z; Liu J; Li L; Nie D; Tao Q; Wu J; Fan J; Lin C; Zhao S; Ju D
PLoS One; 2015; 10(8):e0135236. PubMed ID: 26288183
[TBL] [Abstract][Full Text] [Related]
19. miR-1278 sensitizes nasopharyngeal carcinoma cells to cisplatin and suppresses autophagy via targeting ATG2B.
Zhao Y; Wang P; Wu Q
Mol Cell Probes; 2020 Oct; 53():101597. PubMed ID: 32407879
[TBL] [Abstract][Full Text] [Related]
20. CircIPO7 Promotes Nasopharyngeal Carcinoma Metastasis and Cisplatin Chemoresistance by Facilitating YBX1 Nuclear Localization.
Hong X; Li Q; Li J; Chen K; He Q; Zhao Y; Liang Y; Zhao Y; Qiao H; Liu N; Ma J; Li Y
Clin Cancer Res; 2022 Oct; 28(20):4521-4535. PubMed ID: 35917517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]